WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE:MRK) today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger. The event included a comprehensive review of the company’s late-stage pipeline, as well as the company’s commercial strategy and progress made in the integration of Merck’s worldwide operations. In addition, the company outlined how its growth strategy is designed to meet the evolving needs of the global health care environment.
